Evaluation of sterilization using the MEH200® (cotton pack) in vascular access puncture.
BACKGROUND
In recent years, chlorhexidine-alcohol has been attracting increasing attention for its role in skin antisepsis. There have been few reports on the infection frequency associated with vascular access and no reports on the infection frequency associated with antiseptics.


OBJECTIVE
We investigated skin disinfection during vascular access puncture in patients on chronic hemodialysis (HD).


METHODS
We analyzed patients on chronic HD with arteriovenous fistula (AVF) and arteriovenous graft (AVG) between January 2006 and December 2010.


RESULTS
The MEH200® (cotton pack including alcohol and chlorhexidine gluconate) was used in 97% of patients. A total of 1130 patients were analyzed, including 911 with AVF and 219 with AVG. Of these, seven with AVF had an infection attributed to the insertion site, which represented a rate of 0.008% of patients per year. Twenty patients with AVG had an infection attributed to the insertion site, which represented a rate of 9.1% of patients per year. The frequency was not higher than that previously reported.


CONCLUSIONS
In HD patients, the MEH200® may be effective for the prevention of bacteremia.
Department of Kidney Disease, Kawashima Hospital, Tokushima - Japan.
Yuka
Y
Ueda
Department of Kidney Disease, Kawashima Hospital, Tokushima - Japan.
Kenji
K
Tsuchida
Department of Kidney Disease, Kawashima Hospital, Tokushima - Japan.
Daigo
D
Okada
Department of Kidney Disease, Kawashima Hospital, Tokushima - Japan.
Yasuto
Y
Muromiya
Department of Kidney Disease, Kawashima Hospital, Tokushima - Japan.
Takehiro
T
Suenaga
Department of Kidney Disease, Kawashima Hospital, Tokushima - Japan.
Narushi
N
Yokota
Department of Kidney Disease, Kawashima Hospital, Tokushima - Japan.
Kana
K
Kawahara
Department of Nephrology, Tokushima University, Tokushima - Japan.
Kojiro
K
Nagai
Department of Urology, Tokushima University, Tokushima - Japan.
Hiro-omi
HO
Kanayama
Department of Kidney Disease, Kawashima Hospital, Tokushima - Japan.
Jun
J
Minakuchi
D000279:Administration, Cutaneous; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage*; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects; D016470:Bacteremia / Q000382:microbiology / Q000517:prevention & control*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects; D002710:Chlorhexidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004203:Disinfection / Q000379:methods*; D000431:Ethanol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009339:Needles; D011677:Punctures; D006435:Renal Dialysis / Q000009:adverse effects; D012867:Skin / Q000382:microbiology*; D016896:Treatment Outcome
D000891:Anti-Infective Agents, Local; D000431:Ethanol; C010882:chlorhexidine gluconate; D002710:Chlorhexidine